Health Innovation Research

NEW STUDY ANNOUNCEMENT

Satiety Study

Are you overweight & want to play your part in new appetite control research?

Check your eligibility here

RDC Global is conducting a study to evaluate the effect of an orally-dosed herbal extract, Slimaluma capsules, appetite control and body composition in approximately 120 overweight (as defined by WHO criteria) men and women aged between 20 – 50 years.

Background

Obesity represents a major health and societal concern for not only Australia but also the entire globe. In 2014-15, 63.4% of Australian adults were overweight or obese. It is suggested by 2015, 70% of Australian adults will be classed as overweight or obese. To help stop this concerning trend, many dietary supplements have been formulated for use in conjunction with diet and exercise to promote weight loss. Further research into the use and effectiveness of such dietary supplements is required.

About the product you'll help test...a natural appetite suppressant.

Slimaluma is a commercially available capsule-form herbal medicine containing Caralluma Fimbriata extrac. C Fimbriata is an edible succulent plant native to India and is commonly cooked as a vegetable or eaten raw. C Fimbriata has been traditionally used to suppress hunger and is currently marketed as an appetite suppressant for weight loss and obesity.

About the study you'll take part in...health assessment & monitoring

Once enrolled in the trial, participants will be randomly allocated to either the placebo or active group (60 people per group). Satiety, dietary intake, body composition and tolerance will be assessed at enrolment. Within the week pre-treatment, participant’s blood will be collected for analysis of pre-treatment blood markers. All participants will receive the same standard advice regarding diet and physical activity.

Participants will be asked to take the allocated product according to the dose prescribed. In addition, participants will be asked to attend the study site at weeks 4, 8 and 12 for a body composition, satiety, dietary intake and tolerance assessment.

At the completion of the study (week 16), an assessment identical to what was undertaken at enrolment will be carried out.

About the benefits of taking part...body composition analysis.
  • DXA (dual energy x-ray absorptiometry) body composition scans at the commencement and conclusion of the study.
  • Blood analysis at the commencement and conclusion of the study.
  • You will be helping to advance medical research.
Check if you can take part...study participant requirements
  • Males and females aged between 20 and 50 years.
  • Overweight but not clinically obese (BMI between 25-34.9)
  • Not currently taking any supplements or functional foods targeted at appetite control and/or weight loss
  • Otherwise healthy

Your BMI calculator

Calculate your Body Mass Index (BMI) here…if your BMI is between 25 and 34.9, we would love your help on this study.

Your BMI is

Powered by BMI Calculator

Your rights and privacy.

Your records relating to this study and any other information received will be kept strictly confidential. Upon completion, the results of the study will be shared with you. Qualified medical professionals will supervise your care.

About the location of the study...you'll attend clinic appointments

Our clinic is conveniently located in Doggett Street, Newstead, Brisbane.

We are walking distance from the Commercial Road Ferry Terminal & local buses, and a quick 10 minute walk from Bowen Hills train station. We also have onsite visitor parking available.

Share This